Bausch Health Companies Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-02-17 17:35:32 ET
More on Bausch Health Companies
- Bausch Health: RED-C Failure Leaves Blockbuster Xifaxan Without A Successor
- Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference
- Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Bausch Health falls on phase 3 failure of liver disease complications drug
- Bausch Health sets 2025 outlook at the higher end of the prior range
Read the full article on Seeking Alpha
For further details see:
Bausch Health Companies Q4 2025 Earnings Preview
Bausch Health Companies Inc.
NASDAQ: BHC:CC
BHC:CC Trading
-0.34% G/L:
$5.88 Last:
1,784,767 Volume:
$5.90 Open:
BHC:CC Latest News
February 23, 2026 08:00:00 am
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada
February 19, 2026 08:00:00 am
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres
